The Chemours Company (CC), a provider of industrial and specialty chemicals products, Monday reported net loss of $27 million or $0.18 per share for the third quarter, compared with net profit of $12 million, or $0.08 per share in the same quarter a year ago, primarily impacted by a non-cash impairment charge of $56 million.
Excluding one-time items, earnings rose to $61 million or $0.40 per share from $65 million or $0.43 per share last year.
Sales for the quarter were $1.501 billion, up from $1.487 billion in the previous year.
On average, 9 analysts expected the company to report earnings of $0.28 per share on sales of $1.44 billion for the quarter. Analysts' estimates typically exclude special items.
For the fourth quarter, the company anticipates sales to decrease in the mid to high-single digits sequentially.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.